Statins are a well-established class of β-Hydroxy β-methylglutaryl Coenzyme A (HMG-CoA) reductase inhibitors that have recently been discussed as a possible therapeutic in COVID-19. The breadth of this chapter reviews the evidence for use of statins alone or in combination with other drugs as treatment for patients hospitalized with moderate to severe COVID-19. Discussion will include a (1) biochemical argument for the role of statins in COVID-19, (2) a systematic literature review of relevant studies to date, and (3) an investigation into early-phase interventional studies. Outcome measures based on all aforementioned relevant studies will be clearly defined and compared.
Part of the book: Statins